Close Menu

NEW YORK – Bruker on Friday released final Q4 and full year 2020 results showing Q4 revenues up 8 percent year over year and full-year revenues up 9 percent.

The company reported preliminary revenues on Feb. 18 but postponed reporting of final results due to an allegation regarding accounting irregularities. After an investigation the company found that its financial results, including revenue and operating income, were unchanged from those in its preliminary report.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Russia says its candidate SARS-CoV-2 vaccine has a very high efficacy rate in an initial analysis of clinical trial data, according to the Financial Times.

Wired reports on a microbial analysis of sketches drawn by Leonardo DaVinci.

A new survey explores coronavirus vaccine hesitancy among Black and Latino individuals, the Washington Post reports.

In Nucleic Acids Research this week: the Aging Atlas database, a database of human metagenome-related metadata, and more.